Clinical Trials Browser

Phase NA × OTHER × Trastuzumab × Clear all

NCT02226276 2026-02-13

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Phase NA Active not recruiting

10 enrolled 8 charts

Breast Neoplasms

NCT07115095 2025-08-11

Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer

Phase NA Completed

HER2-positive Breast Cancer

NCT06035679 2025-03-12

Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer

Phase NA Recruiting

Breast Cancer Female

NCT01897441 2024-12-24

Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

Phase NA Terminated

31 enrolled 11 charts

Breast Neoplasms

NCT05656079 2022-12-19

easy laugh

Phase NA Unknown

Breast Neoplasms

NCT01295086 2020-11-02

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Phase NA Completed

Adenocarcinoma

NCT00496808 2020-09-23

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

Phase NA Completed

69 enrolled 6 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03756064 2019-08-13

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Phase NA Unknown

Breast Diseases, Breast Neoplasms

NCT03843749 2019-02-18

Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms

NCT00681993 2019-01-22

PBIC

Phase NA Completed

Breast Neoplasms

NCT02102438 2016-08-31

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

Phase NA Withdrawn

Breast Neoplasms

NCT01048099 2016-01-29

Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

Phase NA Completed

283 enrolled 8 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00896376 2015-02-10

Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT00433407 2012-10-04

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Phase NA Completed

BreastGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Breast Neoplasms, Male, Small Cell Lung Carcinoma